©The Author(s) 2026.
World J Orthop. Feb 18, 2026; 17(2): 112757
Published online Feb 18, 2026. doi: 10.5312/wjo.v17.i2.112757
Published online Feb 18, 2026. doi: 10.5312/wjo.v17.i2.112757
Table 3 Characteristics of the cases with early postoperative infection, n (%)/mean ± SD
| Measurement period | 2007 to June 15, 2019 (n = 19) | After June 15, 2019 (n = 14) | P value |
| Age (years) | 80.96 ± 12.1 | 78.6 ± 8.5 | P = 0.5 (NS, t test1) |
| BMI | 27.9 ± 7.1 | 25.6 ± 7 | P = 0.36 (NS, t test) |
| Diabetes mellitus | 4 (21) | 7 (50) | P = 0.136 (NS, Fisher’s exact test) |
| Chronic kidney disease | 5 (26.3) | 3 (21.4) | P = 1 (NS, Fisher’s exact test) |
| Time of presentation (weeks) | 5 ± 2.5 | 4.5 ± 2.6 | P = 0.58 (NS, t test) |
- Citation: Nageeb Mahmoud AM, Maniar HH, Bernate J, Horwitz DS. Weight-adjusted low molecular weight heparin with surgery morning dose administration: Impact on hip hemiarthroplasty early infections. World J Orthop 2026; 17(2): 112757
- URL: https://www.wjgnet.com/2218-5836/full/v17/i2/112757.htm
- DOI: https://dx.doi.org/10.5312/wjo.v17.i2.112757